Block listing Interim Review

Summary by AI BETAClose X

British American Tobacco PLC has filed a six-monthly return for its Sharesave Scheme, reporting that during the period from July 1, 2025, to December 31, 2025, 38,298 ordinary shares were issued under one part of the scheme, leaving 74,993 shares unissued. The total number of ordinary shares in issue at the end of this period stands at 2,312,454,501, which includes 132,988,352 shares held in treasury.

Disclaimer*

British American Tobacco PLC
02 January 2026
 

SCHEDULE 5

 

BLOCKLISTING SIX MONTHLY RETURN

 

1. Name of company

BRITISH AMERICAN TOBACCO P.L.C.

2. Name of scheme

A)           BRITISH AMERICAN TOBACCO P.L.C. Sharesave Scheme - 1,500,000 Ordinary shares of 25p each (Ref: 0287580) (GB0002875804)

B)            BRITISH AMERICAN TOBACCO P.L.C. Sharesave Scheme - 1,500,000 Ordinary shares of 25p each (Ref: 0287580) (GB0002875804)

3. Period of return: 

From 1 July 2025 to 31 December 2025

4. Balances under scheme from previous return:

A)           113,291

B)             1,500,000

5. The amount by which the block scheme has been increased, if the scheme has been increased since the date of the last return:

A)           N/A

B)            N/A

6. Number of securities issued/allotted under scheme during period:

A)           38,298

B)           0

7. Balance under scheme not yet issued/allotted at end of period:

A)           74,993

B)           1,500,000

8. Number and class of securities originally listed and the date of admission:

A)           1,500,000 listed on 01.05.15 (REF: 0287580) (GB0002875804)

B)           1,500,000 listed on 03.03.25 (REF: 0287580) (GB0002875804)

9. Total number of securities in issue at the end of the period:

2,312,454,501 Ordinary Shares of 25p each which figure includes 132,988,352 shares held in Treasury.

 

Contact for queries:

Name: C. Worlock

Address: Globe House, 4 Temple Place, London WC2R 2PG

Telephone: +44 20 7845 1976

Date: 2 January 2026

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings